Cardiology @Point of Care Podcasts http://atpointofcare.com/ Pinecast (https://pinecast.com) en-US@Point of Care @Point of Care atpointofcare@gmail.com no Cardiology @Point of Care Podcasts http://atpointofcare.com/ https://storage.pinecast.net/podcasts/covers/9390013d-4538-4238-b121-1e96dc04785f/Cardiology.png episodic Copyright 2021 At Point of Care, LLC. All rights reserved. S6:E2 – Best Practices for ATTR-CM Management https://pinecast.com/guid/999d1e14-61d6-46b3-9837-0ffebaa1273c Thu, 15 May 2025 06:11:52 -0000 00:36:28 https://suitehome.atpointofcare.com/library/2684.12/page/0?subdomain=amyloidosis In this episode, our Faculty, Dr. Nitasha Sarswat and Dr. Michelle Kittleson, discuss how biomarkers come into play for the diagnosis of transthyretin amyloid cardiomyopathy, or ATTR-CM. They will also discuss the latest therapeutic landscape, what the latest trial data show, and what’s in the pipeline.

Visit https://suitehome.atpointofcare.com/library/2684.12/page/0?subdomain=amyloidosis to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

]]> Best Practices for ATTR-CM Management no 6 2 S6:E1 – Don't Miss This: A Clinician's Call to Greater ATTR-CM Awareness and Early Diagnosis https://pinecast.com/guid/56a4332d-5ad8-44ef-9bc3-32505baf6601 Thu, 15 May 2025 06:08:18 -0000 00:28:52 https://suitehome.atpointofcare.com/library/2684.11/page/0?subdomain=amyloidosis In this episode, our Faculty, Dr. Nitasha Sarswat and Tracy Joshi, DNP, discuss the often misdiagnosed condition transthyretin amyloid cardiomyopathy. What are the diagnostic red flags clinicians should be aware of, and what diagnostic tools are helpful to ensure their patients get the right diagnosis?

Visit https://suitehome.atpointofcare.com/library/2684.11/page/0?subdomain=amyloidosis to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

]]> Don't Miss This: A Clinician's Call to Greater ATTR-CM Awareness and Early Diagnosis no 6 1 S5:E2 – Precision Medicine in IBD https://pinecast.com/guid/75def5ec-e26c-4a27-917e-bb0d20231dcb Wed, 30 Apr 2025 07:01:00 -0000 00:25:18 https://suiteweb.atpointofcare.com/#library/ibd/2675.02/page/0 In this episode, Precision Medicine in IBD, Dr. Bruce Sands and Dr. Marla Dubinsky take a look at precision medicine in treating irritable bowel disease (IBD), what comprises this approach to care, and how can clinicians best implement it into the day-to-day care of their patients with IBD.   Visit https://suiteweb.atpointofcare.com/#library/ibd/2675.02/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

]]> Precision Medicine in IBD no 5 2 S5:E1 – Breaking Tradition for Proactive Approaches to IBD Care https://pinecast.com/guid/ff749d33-d100-4eb0-b948-f240a8844352 Wed, 30 Apr 2025 07:00:00 -0000 00:29:04 https://suiteweb.atpointofcare.com/#library/ibd/2675.01/page/0 In this episode, Breaking Tradition for Proactive Approaches to IBD Care, Dr. Bruce Sands and Dr. Marla Dubinsky discuss the importance of early intervention and treating to target. How can clinicians optimize treatment for their patients with irritable bowel disease (IBD) so they achieve the best possible outcomes?   Visit https://suiteweb.atpointofcare.com/#library/ibd/2675.01/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

]]> Breaking Tradition for Proactive Approaches to IBD Care no 5 1 S4:E2 – Attractive Therapies on the Horizon for ATTR-CM https://pinecast.com/guid/c4bcaf46-f982-4b57-8fb5-993ea5ecf0b3 Thu, 15 Aug 2024 16:31:19 -0000 00:36:25 https://suitehome.atpointofcare.com/library/2649.12/page/0?subdomain=amyloidosis Visit Attractive Therapies on the Horizon for ATTR-CM to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

In this episode our faculty discuss some of the recent developments in the therapeutic landscape, and look at some exciting presentations coming out of the 2024 International Symposium on Amyloidosis.

]]> Attractive Therapies on the Horizon for ATTR-CM no 4 2 S4:E1 – The Clock Is Ticking on ATTR-CM https://pinecast.com/guid/59a47c3c-d73c-4f2e-ba5b-c1405d1e595d Thu, 15 Aug 2024 16:29:19 -0000 00:28:52 https://suiteweb.atpointofcare.com/#library/amyloidosis/2649.11/page/0 Visit The Clock Is Ticking on ATTR-CM to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

In this episode our faculty discuss the clinical manifestations and how to correctly diagnosis transthyretin amyloid cardiomyopathy (ATTR-CM). What should clinicians know in order to make an accurate and timely diagnosis?

]]> The Clock Is Ticking on ATTR-CM no 4 1 S3:E6 – Heart Failure Morning Commute: Decisions in the Management of Heart Failure https://pinecast.com/guid/fc1b5fef-828f-4318-9ca6-f32649ad3e1d Mon, 28 Mar 2022 16:35:24 -0000 00:25:12 http://www.morningcommutepodcast.com/heartfailure6 When should heart failure therapies be combined, switched, or stopped? Our faculty discuss this topic as well as how Covid-19 has impacted heart failure treatment. 

Visit www.morningcommutepodcast.com/heartfailure6 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit

]]> Heart Failure Morning Commute: Decisions in the Management of Heart Failure no 3 6 S3:E5 – Heart Failure Morning Commute: More Heart Failure Drugs, More Choices https://pinecast.com/guid/8ab2450a-0205-47ab-8cb0-694b44d4762c Tue, 01 Mar 2022 04:31:00 -0000 00:20:48 http://www.morningcommutepodcast.com/heartfailure5 With the many therapies that are now available for the treatment of heart failure, who are the best candidates for these medications and what are the potential side effects? Our faculty discuss this and more.

Visit www.morningcommutepodcast.com/heartfailure5 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit

]]> Heart Failure Morning Commute: More Heart Failure Drugs, More Choices no 3 5 S3:E4 – Heart Failure Morning Commute: Managing Heart Failure in Patients With Type 2 Diabetes https://pinecast.com/guid/cf9e3d0f-193b-45e4-aaf5-1214114e2d81 Tue, 01 Mar 2022 04:24:00 -0000 00:21:57 http://www.morningcommutepodcast.com/heartfailure4 In this podcast our faculty discuss treating patients who have diabetes and heart failure and the remarkable story of SGLT-2 inhibitors for this patient population.  

Visit www.morningcommutepodcast.com/heartfailure4 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit

]]> Heart Failure Morning Commute: Managing Heart Failure in Patients With Type 2 Diabetes no 3 4 S3:E3 – Heart Failure Morning Commute: Preventing Heart Failure in High-Risk Patients With Type 2 Diabetes https://pinecast.com/guid/d47c6ba4-ca1e-45c2-82da-02c4c9db7f69 Mon, 28 Feb 2022 17:19:00 -0000 00:21:24 http://www.morningcommutepodcast.com/heartfailure3 How should the patient with diabetes who is at risk of developing heart failure be managed? What medication is needed and how important is prevention through diet and exercise?

Visit www.morningcommutepodcast.com/heartfailure3 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit

]]> Heart Failure Morning Commute: Preventing Heart Failure in High-Risk Patients With Type 2 Diabetes no 3 3 S3:E2 – Heart Failure Morning Commute: Managing Patients With Mid-Range or Preserved EF https://pinecast.com/guid/a0aa9a65-f97c-45fc-891b-500a77742fd4 Mon, 28 Feb 2022 16:10:00 -0000 00:21:15 http://www.morningcommutepodcast.com/heartfailure2 What are the current guidelines for managing patients with heart failure and why are heart failure labels so confusing? Our faculty help decipher these and more in this podcast episode.

Visit www.morningcommutepodcast.com/heartfailure2 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit

]]> Heart Failure Morning Commute: Managing Patients With Mid-Range or Preserved EF no 3 2 S3:E1 – Heart Failure Morning Commute: Patient Diagnosis and Subtype Classification of Heart Failure https://pinecast.com/guid/54c102ac-cc6d-412f-941c-1ac2b2bdae70 Mon, 28 Feb 2022 16:00:00 -0000 00:23:34 http://www.morningcommutepodcast.com/heartfailure1 In this podcast our faculty discuss diagnosing the heart failure patient in the primary care setting. What should the process be for making this diagnosis and how important is taking a complete medical and family history?

Visit www.morningcommutepodcast.com/heartfailure1 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit

]]> Heart Failure Morning Commute: Patient Diagnosis and Subtype Classification of Heart Failure no 3 1 S2:E3 – SGLT-2 Inhibitors Morning Commute: A Clinical Pathway for Action https://pinecast.com/guid/0ed6d6f9-7e06-4a90-b1bf-a355007c0927 Tue, 30 Mar 2021 13:55:00 -0000 00:24:09 http://morningcommutepodcast.com/SGLT2inhibitors6 Visit http://morningcommutepodcast.com/SGLT2inhibitors6 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode, Dr. James Januzzi and Dr. Silvio Inzucchi discuss the surge in collaboration between primary care physicians, endocrinologists, and cardiologists and the groundswell of cardiometabolic clinics. They attribute this to cardiologists moving beyond the so-called glucocentric view and focusing on how diabetes therapies might help reduce cardiovascular risk as well. Drs. Januzzi and Inzucchi will also discuss the recent guidelines that now incorporate sodium-glucose cotransporter 2 (SGLT-2) inhibitors into clinical pathways.

]]> SGLT-2 Inhibitors Morning Commute: A Clinical Pathway for Action no 2 3 S2:E2 – SGLT-2 Inhibitors Morning Commute: The Heart Failure Connection https://pinecast.com/guid/36f3aac9-1cfa-4432-b2dd-c5ce9d00a190 Tue, 30 Mar 2021 13:50:00 -0000 00:24:06 http://morningcommutepodcast.com/SGLT2inhibitors5 Visit http://morningcommutepodcast.com/SGLT2inhibitors5 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode Dr. James Januzzi and Dr. Silvio Inzucchi discuss how sodium-glucose cotransporter 2 (SGLT-2) inhibitors evolved from treatments for type 2 diabetes mellitus (T2DM) to key treatments for patients with heart failure. Drs. Januzzi and Inzucchi look at the pivotal trials that thrust these treatments into the heart failure treatment limelight.

]]> SGLT-2 Inhibitors Morning Commute: The Heart Failure Connection no 2 2 S2:E1 – SGLT-2 Inhibitors Morning Commute: Widening Benefit https://pinecast.com/guid/3927474a-78b4-4619-ad8e-254737ed6c4d Tue, 30 Mar 2021 13:45:00 -0000 http://morningcommutepodcast.com/SGLT2inhibitors4 Visit http://morningcommutepodcast.com/SGLT2inhibitors4 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode Dr. James Januzzi and Dr. Silvio Inzucchi will discuss SGLT-2 inhibition in cardiovascular risk reduction by taking a look at some of the pivotal clinical trial data.

]]> SGLT-2 Inhibitors Morning Commute: Widening Benefit no 2 1 S1:E2 – Cardiology Journal Club: Treating the Pandemic Heart https://pinecast.com/guid/87672b20-042d-4671-aaf5-aad4c65d7498 Mon, 15 Feb 2021 08:30:00 -0000 00:32:01 Cardiology Journal Club: Treating the Pandemic Heart no 1 2 S1:E1 – Cardiology Journal Club: Special Considerations in Covid-19 and Coagulopathy Risks https://pinecast.com/guid/3960d979-f54d-4e1a-8f2b-afb80dc6ace3 Tue, 22 Dec 2020 17:57:04 -0000 00:37:20 http://journalclubpodcasts.com/cvd

Visit http://journalclubpodcasts.com/cvd to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this Journal Club Podcast our faculty look at venous thrombosis appearing to be a complicated feature of Covid-19 and discuss treatments, including the role of direct oral anticoagulants in the pandemic of Covid-19.

]]> Cardiology Journal Club: Special Considerations in Covid-19 and Coagulopathy Risks no 1 1